Current Trends in Forensic Toxicology Symposium
Join Our Workshop on DART-MS Screening for Benzodiazepines
Join François Espourteille on Tuesday, May 13, for our workshop "Rapid DART-MS Screen for Benzodiazepines in Urine Enabled by DART (Direct Analysis in Real Time) Technology" and discover the power of DART-MS in providing selective results, reducing false positives and negatives, and enabling rapid addition of new target analytes.
Learn about our chromatography-free screening approach for benzodiazepines and their metabolites in urine, including alprazolam, clonazepam, diazepam, and more. This method measures 14 analytes in 96 samples with a throughput of 23 seconds per sample.
Learning Objectives:
- Understand the principles of DART-MS and its advantages over IA-based screening.
- Learn the rapid, chromatography-free screening method for benzodiazepines.
- Gain insights into sample preparation and analysis using EVOQ DART-TQ+ mass spectrometer.
And don't miss the chance to hear Jeff Zonderman speak on the benefits and new developements of chromatogrphy-free workflows and join his talk “Bruker, Bringing Chrom-Free To The Masses” on Tuesday, May 13, at 10 am ET.
The workshop and talk are part of the 2025 Online Symposium on Current Trends in Forensic Toxicology by the CFSRE. The symposium, themed “Innovating for a Smarter, Sustainable, and Efficient Future in Forensic Toxicology,” will take place from May 12 - 16, 2025, with sessions from 8:45 am to 12 pm ET each day and afternoon workshops starting at 1 pm ET.
Enhance your knowledge of advanced screening techniques and improve accuracy and efficiency in measuring benzodiazepines. Register now to elevate your skills and stay ahead in the field of analytical chemistry!
CFSRE Online Symposium on Current Trends in Forensic Toxicology 2025
“Innovating for a Smarter, Sustainable, and Efficient Future in Forensic Toxicology”
May 12 - 16, 2025
Bruker Workshop: "Rapid DART-MS Screen for Benzodiazepines in Urine Enabled by DART (Direct Analysis in Real Time) Technology"
May 13, 1pm ET - 2pm ET
Speaker
François Espourteille
Application Development Manager, Bruker Applied Mass Spectrometry
François Espourteille brings over 25 years of expertise in LC-MSMS applications. He earned a BS and MS from The College of William and Mary in Virginia and received a PhD from Rutgers University, followed by a post-doctoral position at Rensselaer Polytechnic Institute. He joined Cohesive Technologies of Franklin, MA in the application group and subsequently managed the application group for Aria and Transcend platforms within Thermo Fisher Scientific until 2014.
For the following decade, François has focused on clinical/toxicological LC-MSMS assays, high-throughput workflows, and 2D LCMS platforms as a consultant. He joined Bruker Applied Mass Spectrometry (BAMS) in 2021 as the DART-MS and Triple Quadrupole Application Manager.
Jeff Zonderman
Senior Vice President of Bruker Applied Mass Spectrometry
Jeffrey Zonderman serves as the Senior Vice President of Bruker Applied Mass Spectrometry, a new division of the company focused on providing mass spectrometry-based solutions for the applied market segments such as forensics, food, environmental, industrial/polymer, and clinical research. Jeffrey graduated from Northeastern University with a bachelor’s in biology and has been involved in mass spectrometry and chromatography for over 30 years. Before joining Bruker, Jeffrey worked in applications, sales/marketing and general management roles. His previous position was CEO of IonSense Inc, a company focusing on ambient ionization technology and commercialized DART (Direct Analysis in Real Time) technology. As Senior VP of Bruker Applied MS, Jeffrey looks to expand the applications of DART technology, amongst others, for chromatography-free mass spectrometry-based workflows.
For Research Use Only. Not for use in clinical diagnostic procedures.